Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 999

Results For "IT"

10125 News Found

Zydus seeks DCGI approval for monoclonal antibodies cocktail
Policy | May 27, 2021

Zydus seeks DCGI approval for monoclonal antibodies cocktail

Cocktails of 2 mAbs based products are better equipped to deal with variants than single mAb based products which have a tendency of losing their efficacy with rapidly generating variants


Cadila Healthcare posts consolidated PAT of Rs. 679 Cr
News | May 27, 2021

Cadila Healthcare posts consolidated PAT of Rs. 679 Cr

Cadila Healthcare has reported total income of Rs.15139.4 crores FY 2020-21


Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21
News | May 27, 2021

Strides Pharma Science posts consolidated PAT of Rs. 46.08 Cr in Q4FY21

Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21


Zydus and TLC sign agreement to market Liposomal Amphotericin B in India
News | May 26, 2021

Zydus and TLC sign agreement to market Liposomal Amphotericin B in India

With the surge of infections in India in the recent days AmphoTLC will address the country's acute liposomal amphotericin B shortage


Alkem Q4FY21 consolidated PAT drops QoQ to Rs. 239.99 Cr
News | May 25, 2021

Alkem Q4FY21 consolidated PAT drops QoQ to Rs. 239.99 Cr

It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.


Cipla to market Roche's Antibody Cocktail in India
Policy | May 25, 2021

Cipla to market Roche's Antibody Cocktail in India

The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19


Glenmark receives ANDA approval for Icatibant Injection
News | May 25, 2021

Glenmark receives ANDA approval for Icatibant Injection

This marks Glenmark's first synthetic decapeptide injectable approval


Bal Pharma launches BALflu, Favipiravir formulation in India
News | May 25, 2021

Bal Pharma launches BALflu, Favipiravir formulation in India

BALflu is approved by DCGI for emergency use for the treatment of COVID-19


Everest Organics launches 'Posaconazole' API
News | May 25, 2021

Everest Organics launches 'Posaconazole' API

Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients


Nanoform and Celanese explore ways to enhance drug delivery
News | May 25, 2021

Nanoform and Celanese explore ways to enhance drug delivery

Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.